OSCRbenzinga

B of A Securities Downgrades Oscar Health to Underperform, Lowers Price Target to $13.5

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on November 6, 2024 by benzinga